Search Results - "Yu, Peter Paul"

Challenges in assessing the clinical utility and economic value of immune checkpoint inhibitor therapies of Cancer by Yu, Peter Paul, Eton, Omar, Garrison, Louis P

“…Advances in the immunotherapy of cancer have prolonged survival for cancer patients, but the clinical and financial impact of treatments must be considered in…”
Get full text

Impact of Merit-Based Immigration Policies on Brain Drain From Low- and Middle-Income Countries by El Saghir, Nagi S, Anderson, Benjamin O, Gralow, Julie, Lopes, Gilberto, Shulman, Lawrence N, Moukadem, Hiba A, Yu, Peter Paul, Hortobagyi, Gabriel

“…Brain drain is the migration of educated and skilled individuals from a less developed region or country to a more economically established one. The Trump…”
Get full text

From Illumination to Innovation: Visualizing the Future-The 2015 Presidential Address by Yu, Peter Paul

Get full text

Creating an infrastructure to address physician and advanced practice provider burnout at a complex community cancer care delivery system by Tray, Alison, Eanniello, Mary Kate, Yu, Peter Paul

“…11015 Background: Oncology clinicians are at risk for developing burnout due to work-related factors such as high acuity patients, long work hours, limited…”
Get full text

Disparities in comprehensive genomic profiling in older patients with gastrointestinal malignancies by Elias, Rawad, Kuang, Zheng, Murphy, Jo-Ellen, Yu, Peter Paul

“…Abstract only 646 Background: Limited data guides the management of older adults with cancer, a patient population that continues to be under-represented in…”
Get full text

Artificial Intelligence, Big Data, and Cancer by Kantarjian, Hagop, Yu, Peter Paul

Get more information

Timing of adjuvant chemotherapy administration for early breast cancer by Salner, Andrew L., Smith, Shelby, Yu, Peter Paul

“…Abstract only 62 Background: Adjuvant chemotherapy treatment has contributed to the reduction in cause-specific mortality from early stage breast cancer by…”
Get full text

Building a Rapid Learning Health Care System for Oncology: The Regulatory Framework of CancerLinQ by SCHILSKY, Richard L, MICHELS, Dina L, KEARBEY, Amy H, YU, Peter Paul, HUDIS, Clifford A

“…Today is a time of unprecedented opportunity and challenge in health care generally and cancer care in particular. An explosion of scientific knowledge, the…”
Get full text

Integrating electronic health records (EHRs) to facilitate cancer biomarker testing: Real-world implementation barriers and solutions by Huelsman, Karen M., Offit, Caroline, Waugh, Wendi, McNair, Christopher, Kurtin, Sandra E., Enstad, Crystal, Rice, Courtney, Osterman, Travis, Yu, Peter Paul, Shepard, Gregg Christian, Martin, Nikki A., Kim, Joseph, Kisiel, Molly, Plotkin, Elana

“…e13649 Background: Effective integration between EHRs and cancer biomarker testing processes is an unmet need across academic and community settings. Despite…”
Get full text

Home-based geriatric oncology care: A feasibility study by Ozcan, Gonca, Braish, Julie, Mohammed, Turab J, Hong, Catriona, Mott, Nicole, Eanniello, Mary, Shahrokni, Armin, Salner, Andrew L., Yu, Peter Paul, Nipp, Ryan David, Elias, Rawad

“…62 Background: The Comprehensive Geriatric Assessment (CGA) improves the outcomes of older patients with cancer, and by identifying of geriatric impairments…”
Get full text

Genetic Cancer Susceptibility Testing: Increased Technology, Increased Complexity by Yu, Peter Paul, Vose, Julie M, Hayes, Daniel F

Get full text

Identification of Lynch syndrome cohort in a hospital system by Salner, Andrew L., Sekerak, Richard, Yu, Peter Paul

“…Abstract only 91 Background: Lynch Syndrome (LS) is a genetically inherited autosomal dominant disease that is the result of germline mutations in mismatch…”
Get full text

The evolution of oncology electronic health records by Yu, Peter Paul

“…Health information technology will transform health care delivery over the coming years. The central element of this will be the electronic health record,…”
Get full text

Impact of a shared-care model between community and academic centers for facilitating access to allogeneic and autologous stem cell transplantation by Fein, Joshua Alexander, McAuliffe, Agnes, Fischer, Kimberly, Brady, Owen, Devlin, Sean M., Willumsen, Silvia, Ozcan, Gonca, Montanaro, Pat, Pristyazhnyuk, Yelena, Digiuseppe, Joseph, Perales, Miguel-Angel, Pfister, David G., Giralt, Sergio, Dailey, Mark, Yu, Peter Paul, Sauter, Craig Steven

“…1510 Background: Despite curative or disease-controlling roles in AML/MDS and MM, access to allogeneic (allo) and autologous (auto) hematopoietic stem cell…”
Get full text

Screening for Lynch Syndrome Among Patients with Colorectal Cancer: Experiences from a Multihospital Health System by Salner, Andrew, Sekerak, Richard, Yu, Peter Paul

“…Objective: To explore the extent to which patients with newly diagnosed colorectal cancer (CRC) received standard of care screening for Lynch syndrome (LS),…”
Get full text

Post-acute sequelae of SARS-CoV-2 infection in patients with cancer by Warner, Jeremy Lyle, Pinato, David J. James, Mishra, Sanjay, Saliby, Renee Maria, Hwang, Clara, Gulati, Shuchi, McKay, Rana R., Labaki, Chris, Griffiths, Elizabeth A., Jani, Chinmay, Yu, Peter Paul, Portuguese, Andrew Jay, Puc, Matthew, Egan, Pamela, Shah, Sumit, Kasi, Anup, Berg, Stephanie A., Flora, Daniel Blake, Accordino, Melissa Kate, Shah, Dimpy P

“…e18746 Background: Most patients with cancer and COVID-19 will survive the acute illness. The longer-term impacts of COVID-19 on patients with cancer remain…”
Get full text

Complications and severity of COVID-19 in patients with head and neck cancer (HNC): A COVID-19 and Cancer Consortium (CCC19) registry analysis by Karivedu, Vidhya, Hsu, Chih-Yuan, Deeken, John F., Jhawar, Sachin R, Stover, Daniel G., Bowles, Daniel W., Hwang, Clara, McKay, Rana R., Ruiz-Garcia, Erika, Bakouny, Ziad, Sabbah, Arielle, Klein, Elizabeth, Yu, Peter Paul, Glover, Michael, Wotman, Michael, Durbin, Eric B., Kulkarni, Amit, Blau, Sibel, Hallmeyer, Sigrun, Wise-Draper, Trisha Michel

“…6031 Background: Patients with cancer have worse outcomes from COVID-19 infection. However, the specific impact of COVID-19 on patients with head and neck…”
Get full text

Simultaneous multi-cancer detection and tissue of origin (TOO) localization using targeted bisulfite sequencing of plasma cell-free DNA (cfDNA) by Oxnard, Geoffrey R., Klein, Eric A., Seiden, Michael, Hubbell, Earl, Venn, Oliver, Jamshidi, Arash, Zhang, Nan, Beausang, John F., Gross, Samuel, Kurtzman, Kathryn N., Fung, Eric T., Yecies, Jessica, Shaknovich, Rita, Fields, Alexander P., Sekeres, Mikkael A., Richards, Donald A., Yu, Peter Paul, Aravanis, Alex, Hartman, Anne-Renee, Liu, Minetta C.

“…Abstract only 44 Background: A noninvasive cfDNA blood test detecting multiple cancers at earlier stages could decrease cancer mortality. In earlier discovery…”
Get full text

Code status and outcomes in patients with cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) registry analysis by Loggers, Elizabeth Trice, Wulff-Burchfield, Elizabeth Marie, Subbiah, Ishwaria Mohan, Khaki, Ali Raza, Egan, Pamela, Farmakiotis, Dimitrios, Phull, Hardeep, Nakasone, Elizabeth, Labaki, Chris, Yu, Peter Paul, Joshi, Monika, Griffiths, Elizabeth A., Wise-Draper, Trisha Michel, Jani, Chinmay, Thakkar, Astha, Puc, Matthew, Hwang, Clara, Mavromatis, Blanche H., Shah, Dimpy P, Warner, Jeremy Lyle

“…Abstract only 12035 Background: In-hospital mortality among patients with cancer (pts) and COVID-19 infection is high. The frequency of, and factors associated…”
Get full text

Thrombotic complications with SARS-CoV-2 infection in patients with cancer on high-risk therapies: Data from the COVID-19 and Cancer Consortium (CCC19) by Gulati, Shuchi, Shah, Surbhi, Kulkarni, Amit, Desai, Aakash, Fu, Julie, Zon, Rebecca, Kumar, Vaibhav, Hsu, Chih-Yuan, Hwang, Clara, Doroshow, Deborah Blythe, Akpan, Imo, Girard, Jennifer, Yu, Peter Paul, McKay, Rana R., Bakouny, Ziad, Connors, Jean, Shah, Dimpy P., Warner, Jeremy Lyle, Rosovsky, Rachel Pam Greenerger, Grivas, Petros

“…Abstract only e18788 Background: Patients (pts) with cancer have a high risk of venous thromboembolic (VTE) complications, further enhanced by anti-cancer…”
Get full text